Senior Vice President - NYBCe, Comprehensive Cell Solutions

New York Blood Center Enterprises•Rye, NY

9d•Hybrid

About The Position

The SVP of CCS will be responsible for providing strategic leadership and direction to the business unit, ensuring operational excellence, financial growth, and a competitive edge in the cell and gene therapy market. The SVP will lead the organization to provide apheresis and manufacturing services to the sponsors of cutting-edge cell and gene therapies, working with clients in the biopharmaceutical and hospital sectors.

Requirements

Advanced degree in life sciences, biotechnology, biochemistry or a related field.
Minimum of 15 years of senior leadership experience
3-5 years in an executive leadership role within a biotechnology, pharmaceutical, or CDMO environment.
Proven track record in the development, manufacturing, and/or commercialization of cell and gene therapies.
Experienced managing internal and external customers and stakeholders.
Ability to travel 25% to NYBCe locations.
Strong understanding of GMP, FDA/EMA regulations, and compliance frameworks in cell and gene therapy.
Cultural competency and the ability to communicate effectively in a culturally sensitive manner with both individuals and groups from diverse backgrounds.
Exceptional leadership and team-building skills, with the ability to inspire and manage diverse teams, including organized labor groups.
Strong financial acumen, with experience in managing a P&L.
Outstanding oral and written communication and interpersonal skills, with the ability to engage with clients, partners, investors, and regulatory bodies.
Deep technical understanding of apheresis, cell and gene therapy development and manufacturing processes.
Strategic thinker with the ability to execute and drive business growth in a highly competitive and regulated market.

Responsibilities

Develop and execute the business unit’s long-term vision, strategy, and business plan, focusing on growth in the cell and gene therapy space.
Stay ahead of industry trends, scientific advancements, and regulatory changes affecting CCS and biopharma industries.
Ensure alignment with the Enterprise’s mission of providing top-tier draw-to-thaw services for cell and gene therapy customers.
Oversee CCS’ operations, ensuring the company delivers high-quality, scalable solutions for clients.
Lead efforts and high-performing teams to continuously improve operational processes, efficiency, and compliance with regulatory standards (e.g., GMP, FDA, EMA), accrediting organizations (e.g., FACT) and industry best practices.
Drive innovation in cell and gene therapy technologies, improving and adopting new development and manufacturing capabilities.
Build and maintain strong relationships with existing and potential clients, identifying opportunities for growth and collaboration.
Ensure high client satisfaction through delivering products on time, maintaining quality standards, and optimizing client experience.
Foster partnerships with key stakeholders in hospitals/institutions, biotech, pharmaceutical companies, industry associations, and regulatory bodies.
Develop financial, key performance indicators and business development strategies to drive growth, increase revenue, and optimize profitability while managing risk.
Oversee budgeting, financial planning, pricing strategies, and forecasting, ensuring the business unit meets or exceeds revenue and EBITDA targets.
Work with CEO and CFO to secure funding for expansion, technological advancements, and growth initiatives.
Ensure adherence to all regulatory requirements, including FDA, EMA, and other global and state health authorities, for the development and manufacturing of cell and gene therapies.
Champion the implementation of robust quality systems and processes, maintaining the highest levels of compliance in manufacturing and clinical trials.
Lead, mentor, and inspire the executive team and broader organization to perform at their best, fostering a culture of innovation, collaboration, and accountability.
Build a high-performing, cross-functional team, attracting and retaining top talent in the fields of apheresis nursing, cell and gene therapy development, manufacturing, and regulatory compliance.
Champion diversity, equity, and inclusion within the organization.
Foster partnerships through NYBC and CCS to ensure the seamless delivery of services to customers, while coordinating timely use of G&A resources.
Drive the department’s process and analytical development efforts, encouraging innovation in cell and gene therapy technologies.
Position the business unit as a leader in the rapidly evolving cell and gene therapy market by exploring emerging opportunities in advanced therapies and therapeutic apheresis.
Assess and manage the department’s risks, including operational, financial, regulatory, and market risks, ensuring that adequate safeguards are in place.
Implement and oversee crisis management strategies, ensuring business continuity and resilience in response to unforeseen challenges.